These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 34404590)

  • 21.
    Yang J; Li J; Xiao L; Zhou M; Fang Z; Cai Y; Tang Y; Hu S
    Cancer Imaging; 2023 Sep; 23(1):81. PubMed ID: 37667341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous
    Eiber M; Weirich G; Holzapfel K; Souvatzoglou M; Haller B; Rauscher I; Beer AJ; Wester HJ; Gschwend J; Schwaiger M; Maurer T
    Eur Urol; 2016 Nov; 70(5):829-836. PubMed ID: 26795686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CONFIRM trial protocol: the utility of prostate-specific membrane antigen positron emission tomography/computed tomography in active surveillance for prostate cancer.
    Bagguley D; Harewood L; McKenzie D; Ptasznik G; Ong S; Chengodu T; Woon D; Sim K; Sheldon J; Lawrentschuk N
    BJU Int; 2024 Apr; 133 Suppl 4():27-36. PubMed ID: 37904302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic performance of
    Ferraro DA; Becker AS; Kranzbühler B; Mebert I; Baltensperger A; Zeimpekis KG; Grünig H; Messerli M; Rupp NJ; Rueschoff JH; Mortezavi A; Donati OF; Sapienza MT; Eberli D; Burger IA
    Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3315-3324. PubMed ID: 33620559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 68Ga-PSMA PET/CT evaluation in men enrolled in prostate cancer Active Surveillance.
    Pepe P; Pepe L; Tamburo M; Marletta G; Savoca F; Pennisi M; Fraggetta F
    Arch Ital Urol Androl; 2023 May; 95(2):11322. PubMed ID: 37212907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic value of integrated
    Zeng Y; Leng X; Liao H; Jiang G; Chen P
    Prostate Int; 2022 Jun; 10(2):108-116. PubMed ID: 35510079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual-tracer PET/CT-targeted, mpMRI-targeted, systematic biopsy, and combined biopsy for the diagnosis of prostate cancer: a pilot study.
    Qiu DX; Li J; Zhang JW; Chen MF; Gao XM; Tang YX; Zhang Y; Yi XP; Yin HL; Gan Y; Wang GL; Zu XB; Hu S; Cai Y
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2821-2832. PubMed ID: 34860277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of
    Zhou C; Tang Y; Deng Z; Yang J; Zhou M; Wang L; Hu S
    EJNMMI Res; 2022 Feb; 12(1):10. PubMed ID: 35147810
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Liu C; Liu T; Zhang Z; Zhang N; Du P; Yang Y; Liu Y; Yu W; Li N; Gorin MA; Rowe SP; Zhu H; Yan K; Yang Z
    J Nucl Med; 2020 Sep; 61(9):1314-1319. PubMed ID: 32034111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy.
    Geboers B; Meijer D; Counter W; Blazevski A; Thompson J; Doan P; Gondoputro W; Katelaris A; Haynes AM; Delprado W; O'Neill G; Yuen C; Vis AN; van Leeuwen PJ; Ho B; Liu V; Lee J; Donswijk ML; Oprea-Lager D; Scheltema MJ; Emmett L; Stricker PD
    BJU Int; 2024 Apr; 133 Suppl 4():14-22. PubMed ID: 37858931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using a novel PSMA-PET and PSA-based model to enhance the diagnostic accuracy for clinically significant prostate cancer and avoid unnecessary biopsy in men with PI-RADS ≤ 3 MRI.
    Li Y; Li J; Yang J; Xiao L; Zhou M; Cai Y; Rominger A; Shi K; Seifert R; Gao X; Tang Y; Hu S
    Eur J Nucl Med Mol Imaging; 2024 Oct; ():. PubMed ID: 39404788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SUVmax/ADC Ratio as a Molecular Imaging Biomarker for Diagnosis of Biopsy-Naïve Primary Prostate Cancer.
    Chinnappan S; Chandra P; Kumar JS; Chandran G; Nath S
    Indian J Nucl Med; 2021; 36(4):377-384. PubMed ID: 35125755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic Accuracy of Prebiopsy Ga-68 PSMA PET/CT in Detecting Primary Prostate Carcinomas with Prostate-Specific Antigen <50 ng/ml.
    Chandra P; Rajaian S; Krishnamurthy K; Murugasen L; Chandran G; Kumar JS; Nath S
    Indian J Nucl Med; 2020; 35(4):283-290. PubMed ID: 33642751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective comparison of whole-body MRI and
    Sawicki LM; Kirchner J; Buddensieck C; Antke C; Ullrich T; Schimmöller L; Boos J; Schleich C; Schaarschmidt BM; Buchbender C; Heusch P; Rabenalt R; Albers P; Antoch G; Müller HW; Hautzel H
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1542-1550. PubMed ID: 30879122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Could 68Ga-PSMA PET/CT Evaluation Reduce the Number of Scheduled Prostate Biopsies in Men Enrolled in Active Surveillance Protocols?
    Pepe P; Roscigno M; Pepe L; Panella P; Tamburo M; Marletta G; Savoca F; Candiano G; Cosentino S; Ippolito M; Tsirgiotis A; Pennisi M
    J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743547
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
    Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Gondoputro W; Doan P; Katelaris A; Scheltema MJ; Geboers B; Agrawal S; Liu Z; Yaxley J; Savdie R; Rasiah K; Frydenberg M; Roberts MJ; Malouf D; Wong D; Shnier R; Delprado W; Emmett L; Stricker PD; Thompson J
    Transl Androl Urol; 2023 Oct; 12(10):1598-1606. PubMed ID: 37969779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The risk of prostate cancer on incidental finding of an avid prostate uptake on 2-deoxy-2-[
    Franklin A; Gianduzzo T; Kua B; Wong D; McEwan L; Walters J; Esler R; Roberts MJ; Coughlin G; Yaxley JW
    Asian J Urol; 2024 Jan; 11(1):33-41. PubMed ID: 38312828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gallium-68-prostate-specific membrane antigen (
    van Leeuwen PJ; Donswijk M; Nandurkar R; Stricker P; Ho B; Heijmink S; Wit EMK; Tillier C; van Muilenkom E; Nguyen Q; van der Poel HG; Emmett L
    BJU Int; 2019 Jul; 124(1):62-68. PubMed ID: 30074667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. False-positive mpMRI and true-negative
    Tang Y; Yang J; Zhou C; Li J; Hu S
    Transl Androl Urol; 2022 Apr; 11(4):561-566. PubMed ID: 35558264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.